InsidersTradesSigma
Track the 프로티아 share price and the full insider trade history of the company, a listed equity based in South Korea. Shares trade on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 프로티아 has recorded 29 reports. Market capitalisation: €62.7bn. The latest transaction was disclosed on 10 April 2026 (Purchase). Among the most active insiders: 임국진. The full history is free.
29
Insider Decl.
n/a
Thresholds
n/a
13 ops.
Buy Volume
€79,219
4 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 3,605 of 29,062 companies
71.8
score / 100
Value58
Quality86
FCF yld2.9%
Earn yld6.9%
EV/EBITDA13.8x
ROE16%
Gross mgn62%
Net mgn30%
Debt/EBITDA0.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 10 April 2026
Declarations29 total
292,881 sharesKRXDART:20240715000351
25 of 29 declarations
Acerca de 프로티아
Protia es una empresa que opera en el sector de la salud y farmacéutico, cotizando en el mercado XKRX. Se enfoca en desarrollar soluciones innovadoras para mejorar la salud de los pacientes.